Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants.

about

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

P2860

Q47568034-C04079C0-2BD5-4D23-8054-29BF961051F1

P2860

Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants.

Item

http://www.wikidata.org/entity/Q39167922

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Development and verification o ...... /rhIGFBP-3 in preterm infants.

@en

Development and verification o ...... /rhIGFBP-3 in preterm infants.

@nl

type

Item

label

Development and verification o ...... /rhIGFBP-3 in preterm infants.

@en

Development and verification o ...... /rhIGFBP-3 in preterm infants.

@nl

prefLabel

Development and verification o ...... /rhIGFBP-3 in preterm infants.

@en

Development and verification o ...... /rhIGFBP-3 in preterm infants.

@nl

P1476

Development and verification o ...... /rhIGFBP-3 in preterm infants.

@en

P2093

Adina Tocoian

http://www.w3.org/2001/XMLSchema#string

Boubou Hallberg

http://www.w3.org/2001/XMLSchema#string

David Ley

http://www.w3.org/2001/XMLSchema#string

Gerald Fetterly

http://www.w3.org/2001/XMLSchema#string

Ingrid Hansen-Pupp

http://www.w3.org/2001/XMLSchema#string

Jou-Ku Chung

http://www.w3.org/2001/XMLSchema#string

Jyoti Sharma

http://www.w3.org/2001/XMLSchema#string

Martin A Graham

http://www.w3.org/2001/XMLSchema#string

Nerissa C Kreher

http://www.w3.org/2001/XMLSchema#string

Norman Barton

http://www.w3.org/2001/XMLSchema#string

P2860

Innovative clinical trial design for pediatric therapeutics

Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development

Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety

Clinical trials of drugs used off-label in neonates: ethical issues and alternative study designs.

Unlicensed and off label drug use in neonates

A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants

Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity.

Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010.

Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.

Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation.

P2888

pr.2016.255

P304

504-510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/PR.2016.255

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ann Hellström

P577

2016-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27870826

http://www.w3.org/2001/XMLSchema#string

P921

preterm infant

Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants.

about

P2860

P2860

Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921